{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20250306",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230306",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "74106",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/205770Orig1s000ltr.pdf",
              "date": "20230428",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA205770",
      "sponsor_name": "PH HEALTH",
      "openfda": {
        "application_number": [
          "ANDA205770"
        ],
        "brand_name": [
          "BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE"
        ],
        "generic_name": [
          "BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Par Health USA, LLC"
        ],
        "product_ndc": [
          "49884-151"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "BISMUTH SUBCITRATE POTASSIUM",
          "METRONIDAZOLE",
          "TETRACYCLINE HYDROCHLORIDE"
        ],
        "rxcui": [
          "1294619"
        ],
        "spl_id": [
          "1ba717f8-b210-40c9-a16e-85edbddaba02"
        ],
        "spl_set_id": [
          "c4d66e80-f0bc-4e64-a0f0-630ef673da1b"
        ],
        "package_ndc": [
          "49884-151-54"
        ],
        "nui": [
          "N0000175435",
          "M0014907"
        ],
        "pharm_class_epc": [
          "Nitroimidazole Antimicrobial [EPC]"
        ],
        "pharm_class_cs": [
          "Nitroimidazoles [CS]"
        ],
        "unii": [
          "R3O80H60KX",
          "140QMO216E",
          "P6R62377KV"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "BISMUTH SUBCITRATE POTASSIUM",
              "strength": "140MG"
            },
            {
              "name": "METRONIDAZOLE",
              "strength": "125MG"
            },
            {
              "name": "TETRACYCLINE HYDROCHLORIDE",
              "strength": "125MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "CAPSULE",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}